First Time Loading...
Y

Yifan Pharmaceutical Co Ltd
SZSE:002019

Watchlist Manager
Yifan Pharmaceutical Co Ltd
SZSE:002019
Watchlist
Price: 13.24 CNY 3.36%
Updated: May 1, 2024

Yifan Pharmaceutical Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yifan Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yifan Pharmaceutical Co Ltd
SZSE:002019
Cash from Operating Activities
¥456.3m
CAGR 3-Years
-35%
CAGR 5-Years
-20%
CAGR 10-Years
19%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Cash from Operating Activities
¥4.7B
CAGR 3-Years
-11%
CAGR 5-Years
4%
CAGR 10-Years
22%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Operating Activities
¥2.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Operating Activities
¥3.1B
CAGR 3-Years
N/A
CAGR 5-Years
108%
CAGR 10-Years
30%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Operating Activities
¥3.4B
CAGR 3-Years
-13%
CAGR 5-Years
8%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Operating Activities
¥3.5B
CAGR 3-Years
-3%
CAGR 5-Years
18%
CAGR 10-Years
26%

See Also

What is Yifan Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
456.3m CNY

Based on the financial report for Sep 30, 2023, Yifan Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 456.3m CNY.

What is Yifan Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%

Over the last year, the Cash from Operating Activities growth was 85%. The average annual Cash from Operating Activities growth rates for Yifan Pharmaceutical Co Ltd have been -35% over the past three years , -20% over the past five years , and 19% over the past ten years .